G-PUR® for Reduced Dietary Fumonisin Bioavailability

Exclusion Criteria

• •1. Pregnancy or breastfeeding.
• •2. Lack of willingness or capacity to co-operate appropriately
• •3. Regular use of medications in the previous 2 months (except oral contraception)
• •4. History of malignancies within the past two years or on current anticancer treatment
• •5. History of gastrointestinal pathology such as clinically relevant gastritis, gastric ulcers, inflammatory bowel disease, chronic constipation
• •6. History of diarrhoea within the past 14 days of screening
• •7. History of gastrointestinal surgery with exception of appendectomy
• •8. History of any chronic liver disease
• •9. History of autoimmune disease requiring treatment within the past two months of screening
• •10. Known symptomatic food allergies
• •11. Active infection (including HIV and hepatitis B or C), or abnormalities in laboratory testing, vital signs, or physical examination
• •12. Hypersensitivity to aluminium and/or silicon
• •13. Chronic renal disease requiring dialysis
• •14. Alcohol, cigarette or drug abuse
• •15. Presence of any condition that impacts compliance with the study procedures
• •16. Use of any investigational or non-registered product (drug or device) within 30 days preceding the first study product administration, or planned use during the study period
• •17. Employee at the study site, spouse/partner or relative of any study staff (e.g. investigator, sub-investigators, or study nurse) or relationship to the sponsor